Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 11, 1998, Pages 2449-2459

  Vescovo, Giorgio ^a,d   Zennaro, Roberta ^a   Sandri, Marco ^b   Carraro, Ugo ^b   Leprotti, Cristiana ^a   Ceconi, Claudio ^c   Ambrosio, Giovanni Battista ^a   Dalla Libera, Luciano ^b  

^a Venice City Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c IRCCS   (Italy)

^d Ctro Regionale Specializzato P   (Italy)

Author keywords

Bax; Bcl 2; Congestive heart failure; Monocrotaline; Skeletal muscle apoptosis; Skeletal muscle myopathy

Indexed keywords

DNA; FLUORESCENT DYE; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DNA DETERMINATION; ELECTROPHORESIS; ENDOTHELIUM CELL; EXTENSOR DIGITORUM LONGUS MUSCLE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; LEYDIG CELL; MALE; MUSCLE ISCHEMIA; MUSCLE MASS; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ANIMALIA;

EID: 0032212950     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0807     Document Type: Article

References (37)

1. ALLEN DL, LINDERMAN JK, ROY RR, BIGBEE AJ, GRINDELAND RD, MUKKU V, EDGERTON VR, 1997. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am J Physiol 273: C579-C587.
2. ANGELINI A, VESCOVO G, CALLIARI I, VALENTE ML, THIENE G, 1993. Correlation between endomyocardial biopsies and ventricle full thickness samples in dilated cardiomyopathy: A study of myocytes and fibrosis. Cardiovascular Path 3: 167-171.
3. CARRARO U, CATANI C, 1983. A sensitive SDS-page method separating myosin heavy chains isoforms of rat skeletal muscle reveals the heterogeneous nature of the embryonic myosin. Biochim Biophys Res Commun 116: 793-802.
4. CECONI C, CONDORELLI E, QUINZANINI M, RODELLA A, FERRARI R, HARRIS P, 1989. Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats with congestive heart failure. Cardiovascular Res 23: 674-682.
5. COATS AJS, CLARK AL, PIEPOLI M, VOLTERRANI M, POOLE-WILSON PA, 1994. Symptoms and quality of life in heart failure. The muscle hypothesis. Br Heart J 72: 36-39.
6. DREXLER H, RIEDE U, MUNZEL T, KONIG H, FUNKE E, JUST H, 1992. Alterations of skeletal muscle in chronic heart failure. Circulation 85: 1751-1759.
7. GOBÈ G, BROWNING J, HOWARD T, HOGG N, WINTERFORD C, CROSS R, 1997. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. J Struct Biol 118, 63-72.
8. KAY JM, HEATH D, 1969. Crotalaria Spectabilis. The pulmonary Hypertension Plant. Sprigfield, Illinois: Charles C. Thomas Ed. 43-95.
9. KROWN KA, PAGE MT, NGUYEN C, ZECHNER D, GUTIERREZ V, COMSTOCK K, GLEMBOTSKI CC, QUINTANA PJE, SABBADINI R, 1996. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854-2865.
10. LIPKIN D, JONES D, ROUND J, POOLE-WILSON PA, 1988. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 18: 187-195.
11. LOWRY OH, 1951. Protein measure with the Folin phenol reagent. J Biol Chem 195: 265-275.
12. MALLAT Z, TEDGUI A, FONTALIRAN F, FRANK R, DURIGON M, FONTAINE G, 1996. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335: 1190-1196.
13. 31P NMR study. Am J Cardiol 62: 1234-1240.
14. 31P NMR skeletal muscle metabolic abnormalities in patients with heart failure. Circulation 80: 1338-1346.
15. MANCINI DM, REICHEK N, CHANCE B, LENKINSKI R, MULLEN J, WILSON JR, 1992. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85: 1364-1373.
16. MASSIE B, CONWAY M, RAJAGOPALAN B, YONGE R, FROSTICK S, LEDINGHAM J, SLEIGHT P, RADDA G, 1988. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: evidence for abnormalities unrelated to blood flow. Circulation 78: 320-326.
17. MCMURREY J, ABDDULLAH I, DARGIE HJ, SHAPIRO D, 1991. Increased concentrations of tumor necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 66: 356-358.
18. NARULA J, HAIDER N, VIRMANI R, DISALVO T, KOLODGIE FD, HAJJAR RJ, SCHMIDT U, SEMIGRAN MJ, DEC GW, KHAW BA, 1996. Apoptosis in myocytes in end-stage heart failure. N. Engl J Med 335: 1182-1189.
19. OLIVETTI G, ABBI R, QUAINI F, KAJSTURA J, CHENG W, NITAKARA JA, QUAINI E, DI LORETO C, BELTRAMI C, KRAJEWSKI S, REED JC, ANVERSA P, 1997. Apoptosis in the failing human heart. N Engl J Med 336: 1131-1141.
20. OLTVAI ZN, KORSMEYER SJ, 1994. Checkpoints of duelling dimers foil death wishes. Cell 79: 189-192.
21. PIEPOLI M, CLARK AL, VOLTERRANI M, ADAMOPULOS S, SLEIGHT P, COATS AJS, 1996. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure. Circulation 93: 940-952.
22. REED JC, 1994. Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6.
23. SANDRI M, CARRARO U, PODHORSKA-OKOLOV M, RIZZI C, ARSLAN P, MONTI D, FRANCESCHI C, 1995. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett 373: 291-295.
24. SANDRI M, PODHORSKA-OKOLOW M, GEROMEL V, RIZZI C, ARSLAN P, FRANCESCHI C, CARRARO U, 1997. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deflcient muscle of mice. J Neuropath Exp Neurol 56: 45-57.
25. SIMONINI A, LONG CS, DUDLEY GA, YUE P, MCELHINNY J, MASSIE B, 1996. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 79: 128-136.
26. STELLER H, 1995. Mechanisms and genes of cellular suicide. Science 267: 1445-1449.
27. SULLIVAN M, GREEN H, COBB F, 1990. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81: 518-527.
28. SWAN JW, WALTON C, GODSLAND IF, CLARK AL, COATS AJS, 1994. Insulin resistance in chronic heart failure. Eur Heart J 15: 1528-1532.
29. TEWS DS, GOEBEL HH, 1997. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropathol Exp Neurol 56: 150-156.
30. TEWS DS, GOEBEL HH, SCHEIDER I, GUNKEL A, STENNERT E, NEISS WF, 1997. DNA-fragmentation and expression of apoptosis-related proteins in experimentally denervated and reinnervated facial muscle. Neuropathol and Appl Neurobiol 23: 141-149.
31. THOMPSON CB, 1996. Apoptosis in the pathogenesis and treatment of disease. Gene Dev 10: 1-15.
32. VESCOVO G, JONES SM, HARDING SE, POOLE-WILSON PA, 1989. Isoproterenol of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and cardiac failure. J Mol Cell Cardiol 21: 1047-1061.
33. VESCOVO G, SERAFINI F, FACCHIN L, TENDERINI P, CARRARO U, DALLA LIBERA L, CATANI C, AMBROSIO GB, 1996. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 76: 337-343.
34. VESCOVO F, SERAFINI F, DALLA LIBERA L, LEPROTTI C, FACCHIN L, TENDERINI P, AMBROSIO GB, 1998a. Skeletal muscle myosin heavy chains in heart failure. Correlation between magnitude of the isozyme shift, exercise capacity and gas exchange measurements. Am Heart J 135(1): 130-137.
35. VESCOVO G, CECONI C, BERNOCCHI P, FERRARI R, CARRARO U, AMBROSIO GB, DALLA LIBERA L, (1998b) Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. Cardiovascular Res; 39: 233-241.
36. WEINER DH, FINK LI, MARIS J, JONES RA, CHANCE B, WILSON JR, 1986. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 73: 1127-1136.
37. WILSON JR, FINK L, MARIS J, FERRARO N, POWER-VANWART J, ELEFF S, CHANCE B, 1985. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 71: 57-62.